CXCL9 and kidney transplant: In summary we suggest CXCL9 (but not CXCL10) testing in urine as an adjunct test to immunodominant DSA characterization in serum for the prediction of late antibody-mediated rejection in clinically well-presenting, but DSA-positive long-term kidney transplant patients.